M. Toppozada

1.6k total citations
81 papers, 1.2k citations indexed

About

M. Toppozada is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. Toppozada has authored 81 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Public Health, Environmental and Occupational Health, 22 papers in Obstetrics and Gynecology and 19 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. Toppozada's work include Reproductive Health and Contraception (23 papers), Pregnancy and Medication Impact (15 papers) and Estrogen and related hormone effects (12 papers). M. Toppozada is often cited by papers focused on Reproductive Health and Contraception (23 papers), Pregnancy and Medication Impact (15 papers) and Estrogen and related hormone effects (12 papers). M. Toppozada collaborates with scholars based in Egypt, Sweden and United States. M. Toppozada's co-authors include M. Bygdeman, N. Wiqvist, K. Gréen, François Béguin, Samy Elwany, Hussein H. Toppozada, L. Michaels, M. Talaat, I. Fernström and S. Bergström and has published in prestigious journals such as The Lancet, American Journal of Obstetrics and Gynecology and Life Sciences.

In The Last Decade

M. Toppozada

78 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Toppozada Egypt 20 649 346 334 155 140 81 1.2k
S.S. Ratnam Singapore 19 486 0.7× 222 0.6× 308 0.9× 68 0.4× 243 1.7× 107 1.2k
A. C. Turnbull United Kingdom 18 345 0.5× 445 1.3× 452 1.4× 85 0.5× 196 1.4× 44 1.3k
Rodney P. Shearman Australia 22 444 0.7× 349 1.0× 290 0.9× 49 0.3× 550 3.9× 90 1.5k
Abdullah Karaer Türkiye 19 321 0.5× 291 0.8× 261 0.8× 75 0.5× 271 1.9× 59 1.0k
A.A. Calder United Kingdom 13 194 0.3× 198 0.6× 155 0.5× 35 0.2× 48 0.3× 19 758
Jean-Claude Challier France 22 280 0.4× 1.3k 3.7× 908 2.7× 47 0.3× 94 0.7× 45 2.1k
J. Elson United Kingdom 15 912 1.4× 455 1.3× 565 1.7× 197 1.3× 396 2.8× 28 1.7k
A.A. Haspels Netherlands 20 496 0.8× 290 0.8× 217 0.6× 15 0.1× 345 2.5× 60 1.1k
Eli Geva Israel 25 735 1.1× 501 1.4× 408 1.2× 40 0.3× 1.0k 7.3× 52 2.0k
Aykan Yücel Türkiye 18 325 0.5× 498 1.4× 337 1.0× 40 0.3× 249 1.8× 112 1.1k

Countries citing papers authored by M. Toppozada

Since Specialization
Citations

This map shows the geographic impact of M. Toppozada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Toppozada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Toppozada more than expected).

Fields of papers citing papers by M. Toppozada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Toppozada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Toppozada. The network helps show where M. Toppozada may publish in the future.

Co-authorship network of co-authors of M. Toppozada

This figure shows the co-authorship network connecting the top 25 collaborators of M. Toppozada. A scholar is included among the top collaborators of M. Toppozada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Toppozada. M. Toppozada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toppozada, M., et al.. (1997). Oral or vaginal misoprostol for induction of labor. International Journal of Gynecology & Obstetrics. 56(2). 135–139. 80 indexed citations
2.
Toppozada, M., et al.. (1997). Effect of Norplant® implants on the pituitary-adrenal axis function and reserve capacity. Contraception. 55(1). 7–10. 1 indexed citations
3.
Toppozada, M.. (1994). Existing once-a-month combined injectable contraceptives. Contraception. 49(4). 293–301. 6 indexed citations
4.
Toppozada, M., et al.. (1994). Termination of pregnancy with fetal death in the second and third trimesters — the double balloon versus extra‐amniotic prostaglandin. International Journal of Gynecology & Obstetrics. 45(3). 269–273. 10 indexed citations
5.
Toppozada, M., et al.. (1992). Improving placental blood flow in pre‐eclampsia with prostaglandin A1. Acta Obstetricia Et Gynecologica Scandinavica. 71(1). 22–27. 2 indexed citations
6.
Toppozada, M., et al.. (1992). Serum nickel, copper and zinc in Norplant(R) users. Contraception. 45(6). 561–572. 3 indexed citations
7.
Toppozada, M., et al.. (1991). Low dose acetyl salicylic acid in severe preeclampsia. International Journal of Gynecology & Obstetrics. 35(4). 311–317. 5 indexed citations
8.
Toppozada, M., et al.. (1991). Management of severe preeclampsia detected in early labor by prostaglandin A1 or dihydralazine infusions. American Journal of Obstetrics and Gynecology. 164(5). 1229–1232. 8 indexed citations
9.
Toppozada, M.. (1990). Role of Prostaglandins in Pre‐Eclampsia. Acta Obstetricia Et Gynecologica Scandinavica. 69(5). 375–377. 6 indexed citations
10.
Toppozada, M., et al.. (1989). Changes in menstrual blood loss after four methods of female tubal sterilization. Contraception. 40(4). 387–398. 17 indexed citations
11.
Toppozada, M., et al.. (1988). Treatment of preeclampsia with prostaglandin A1. American Journal of Obstetrics and Gynecology. 159(1). 160–165. 6 indexed citations
12.
Toppozada, M., et al.. (1987). Prostaglandins and cellular reaction in uterine flushings. I. Effect of IUD insertion. Advances in Contraception. 3(4). 291–302. 7 indexed citations
13.
Toppozada, M., et al.. (1987). Uterine geometry by Wing Sound and hysterography versus direct measurements. Advances in Contraception. 3(3). 237–243. 5 indexed citations
14.
Toppozada, M., et al.. (1987). Effect of prostaglandins E2 and 15-methyl F2α on human pregnant and non-pregnant cervix. European Journal of Obstetrics & Gynecology and Reproductive Biology. 26(1). 27–32. 9 indexed citations
15.
Toppozada, M.. (1987). Treatment of increased menstrual blood loss in iud users. Contraception. 36(1). 145–157. 8 indexed citations
16.
Toppozada, M., et al.. (1987). Prostaglandins and cellular reaction in uterine flushings. II. Effect of PG synthesis inhibition in IUD users. Advances in Contraception. 3(4). 303–313. 2 indexed citations
17.
Toppozada, Hussein H., et al.. (1984). The human respiratory nasal mucosa in females using contraceptive pills. The Journal of Laryngology & Otology. 98(1). 43–51. 55 indexed citations
18.
Toppozada, Hussein H., et al.. (1981). The human nasal mucosa in the menstrual cycle. The Journal of Laryngology & Otology. 95(12). 1237–1247. 28 indexed citations
19.
Toppozada, M., et al.. (1979). Effect of prostaglandin A1 on renal hemodynamics in pregnancy toxemia. American Journal of Obstetrics and Gynecology. 135(5). 581–585. 13 indexed citations
20.
Toppozada, M., et al.. (1977). Management of missed abortion and fetal death in utero. Prostaglandins. 14(3). 583–590. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026